Media

Created in partnership with Informa Pharma Intelligence, this is the only field-wide report covering the therapeutics pipeline, clinical targets, developer progress, and more.

Learn about: 

• Top research areas
• Statistics on therapies in the pipeline
• Latest clinical trials and approvals updates

View all landscape reports

ASGCT's leaders are experts in: 

• Research funding—working closely with NIH Institutes and Centers to address gaps and needs
• Responsible use of gene and cell therapy technologies
• Genetic screening and testing, including for newborns
• Regulatory policy for safe and effective therapies to alleviate human disease
• Patient access to approved therapies—including insurance coverage and innovative payment models

The Society advocates for its members' and patients' needs through legislative meetings, liaising with the FDA, and publishing policy statements and letters. 

Please contact media@asgct.org with any interview requests. 

Read policy statements and research

ASGCT's award-winning free Patient Education site provides scientific, reliable information for patients and the public. Expert members review and update all content. 

View clear and accessible resources on topics such as gene therapy 101 and disease treatments.

Access educational resources

Access ASGCT's curated list of CGT trials sourced from clinicaltrials.gov. You can filter by location, diagnosis, treatment modality, or enrollment status. 

Search for clinical trials

ASGCT is working to foster improved access to gene and cell therapies on a global scale. As part of these efforts, the Society has initiated partnered educational programming to support clinical development in middle-income countries. 

In 2023, ASGCT was recognized for its global impact on gene therapy education in sub-Saharan Africa. The Global Gene Therapy Training course received a Gold Award from the American Society of Association Executives (ASAE).

Learn about ASGCT's global outreach iniatives

ASGCT focuses on diversity, equity, and inclusion efforts that benefit the future and current members of the Society and the communities they serve. Underrepresented groups and individuals within the bio-medical field are essential for scientific and technological innovations. Our goal is to increase awareness and opportunities for education.

In 2022 and 2023, ASGCT led an innovative program to provide Milwaukee teachers with curriculum training and lab equipment so they can bring biotechnology experiments into their classrooms, thanks to a generous grant from Bristol Myers Squibb.

Learn about ASGCT's DEI initiatives